SHS Capital's Strategic Acquisition of Medizintechnik Rostock GmbH

SHS Capital, through its SHS VI fund, has acquired a majority stake in Medizintechnik Rostock GmbH (MTR), a prominent home care provider of medical therapy devices in Germany. Founded in 1994, MTR specializes in movement, electro, and compression therapy devices and has partnered with over 80 health insurance companies. The acquisition aims to expand MTR's core business and national reach.

MTR, employing around 200 people, is a quality leader providing therapy devices that are often covered by health insurance. Their devices, primarily used for movement therapy, support patients post-surgery. Electrotherapy and compression therapy are also key areas, aiding in muscle stimulation and circulation enhancement.

The transition ensures MTR's original shareholders remain involved, maintaining continuity. SHS Capital plans to leverage its healthcare expertise to boost MTR's patient base and strengthen its position in the sector. SHS has invested over half of its fund's capital since the recent closing, indicating robust activity in healthcare investments.